help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Helliwell, R. J. A.
Right arrow Articles by Glass, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Helliwell, R. J. A.
Right arrow Articles by Glass, M.
The Journal of Clinical Endocrinology & Metabolism Vol. 89, No. 10 5168-5174
Copyright © 2004 by The Endocrine Society

Characterization of the Endocannabinoid System in Early Human Pregnancy

Rachel J. A. Helliwell, Lawrence W. Chamley, Katherine Blake-Palmer, Murray D. Mitchell, Janice Wu, Christopher S. Kearn and Michelle Glass

Department of Anatomy with Radiology (R.J.A.H.), Liggins Institute (M.D.M.), Department of Pharmacology and Clinical Pharmacology (K.B.-P., M.D.M., M.G.), and Department of Obstetrics and Gynecology (L.W.C., M.D.M.), University of Auckland, Auckland, New Zealand; and Department of Anesthesiology, University of Washington (J.W., C.S.K.), Seattle, Washington 98195

Address all correspondence and requests for reprints to: Dr. Michelle Glass, Department of Pharmacology, University of Auckland, Private Bag 92019, Auckland, New Zealand. E-mail: m.glass{at}auckland.ac.nz.

In recent years, it has been demonstrated that high circulating levels of the endogenous cannabinoid anandamide, resulting from low expression of its metabolizing enzyme fatty acid amide hydrolase (FAAH), may contribute to spontaneous miscarriage and poor outcome in women undergoing in vitro fertilization. The site of action of this compound, however, has not been determined. In this study, we examined the distribution of the cannabinoid receptors, CB1 and CB2, and the endocannabinoid-metabolizing enzyme FAAH in first trimester human placenta. Here, we show that FAAH is expressed throughout the human first trimester placenta, in extravillous trophoblast columns, villous cytotrophoblasts, syncytiotrophoblasts, and macrophages. Furthermore, FAAH mRNA levels appear to be regulated during gestation, with levels peaking at 11 wk before declining again. The immune system-associated cannabinoid CB2 receptors were localized only to placental macrophages. Interestingly, the cannabinoid receptor CB1 was not identified in first trimester placenta despite having previously been shown to be present in placental tissues at term. These findings suggest that the placenta may form a barrier preventing maternal-fetal transfer of anandamide and/or modulate local levels of anandamide by regulation of FAAH expression with gestation.




This article has been cited by other articles:


Home page
EndocrinologyHome page
O. M. H. Habayeb, A. H. Taylor, S. C. Bell, D. J. Taylor, and J. C. Konje
Expression of the Endocannabinoid System in Human First Trimester Placenta and Its Role in Trophoblast Proliferation
Endocrinology, October 1, 2008; 149(10): 5052 - 5060.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
M. D. Mitchell, T. A. Sato, A. Wang, J. A. Keelan, A. P. Ponnampalam, and M. Glass
Cannabinoids stimulate prostaglandin production by human gestational tissues through a tissue- and CB1-receptor-specific mechanism
Am J Physiol Endocrinol Metab, February 1, 2008; 294(2): E352 - E356.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
A.H. Taylor, C. Ang, S.C. Bell, and J.C. Konje
The role of the endocannabinoid system in gametogenesis, implantation and early pregnancy
Hum. Reprod. Update, September 1, 2007; 13(5): 501 - 513.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. S. Graham, N. Ball, E. L. Scotter, P. Narayan, M. Dragunow, and M. Glass
Induction of Krox-24 by Endogenous Cannabinoid Type 1 Receptors in Neuro2A Cells Is Mediated by the MEK-ERK MAPK Pathway and Is Suppressed by the Phosphatidylinositol 3-Kinase Pathway
J. Biol. Chem., September 29, 2006; 281(39): 29085 - 29095.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
M. Khare, A. H. Taylor, J. C. Konje, and S. C. Bell
{Delta}9-Tetrahydrocannabinol inhibits cytotrophoblast cell proliferation and modulates gene transcription
Mol. Hum. Reprod., May 1, 2006; 12(5): 321 - 333.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
U. Pagotto, G. Marsicano, D. Cota, B. Lutz, and R. Pasquali
The Emerging Role of the Endocannabinoid System in Endocrine Regulation and Energy Balance
Endocr. Rev., February 1, 2006; 27(1): 73 - 100.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
H. Schuel and L. J. Burkman
A Tale of Two Cells: Endocannabinoid-Signaling Regulates Functions of Neurons and Sperm
Biol Reprod, December 1, 2005; 73(6): 1078 - 1086.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2004 by The Endocrine Society